Citadel Advisors’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-200
| Closed | -$592 | – | 14410 |
|
|
2025
Q1 | $592 | Sell |
200
-3,200
| -94% | -$10K | ﹤0.01% | 14236 |
|
|
2024
Q4 | $10.4K | Sell |
3,400
-300
| -8% | -$873 | ﹤0.01% | 13605 |
|
|
2024
Q3 | $9.44K | Sell |
3,700
-14,800
| -80% | -$44.8K | ﹤0.01% | 13256 |
|
|
2024
Q2 | $60.3K | Hold |
18,500
| – | – | ﹤0.01% | 11558 |
|
|
2024
Q1 | $98K | Buy |
18,500
+13,200
| +249% | +$71.1K | ﹤0.01% | 11382 |
|
|
2023
Q4 | $22.9K | Sell |
5,300
-14,800
| -74% | -$49K | ﹤0.01% | 12507 |
|
|
2023
Q3 | $52.9K | Buy |
20,100
+9,100
| +83% | +$31K | ﹤0.01% | 11695 |
|
|
2023
Q2 | $38.8K | Buy |
11,000
+2,000
| +22% | +$6.24K | ﹤0.01% | 12090 |
|
|
2023
Q1 | $27.8K | Sell |
9,000
-5,500
| -38% | -$20.7K | ﹤0.01% | 12804 |
|
|
2022
Q4 | $61.3K | Sell |
14,500
-4,200
| -22% | -$14.5K | ﹤0.01% | 11888 |
|
|
2022
Q3 | $44K | Buy |
+18,700
| New | +$54.6K | ﹤0.01% | 11720 |
|
|
2022
Q2 | – | Sell |
-40,700
| Closed | -$117K | – | 13783 |
|
|
2022
Q1 | $117K | Buy |
40,700
+9,400
| +30% | +$24.3K | ﹤0.01% | 12113 |
|
|
2021
Q4 | $95K | Buy |
31,300
+19,800
| +172% | +$85.9K | ﹤0.01% | 12768 |
|
|
2021
Q3 | $81K | Sell |
11,500
-8,800
| -43% | -$65.9K | ﹤0.01% | 13062 |
|
|
2021
Q2 | $186K | Buy |
20,300
+7,900
| +64% | +$80K | ﹤0.01% | 12243 |
|
|
2021
Q1 | $121K | Sell |
12,400
-18,400
| -60% | -$205K | ﹤0.01% | 12285 |
|
|
2020
Q4 | $316K | Sell |
30,800
-2,200
| -7% | -$22.3K | ﹤0.01% | 8985 |
|
|
2020
Q3 | $333K | Buy |
33,000
+4,700
| +17% | +$47.9K | ﹤0.01% | 7956 |
|
|
2020
Q2 | $295K | Sell |
28,300
-4,600
| -14% | -$47.6K | ﹤0.01% | 7929 |
|
|
2020
Q1 | $278K | Sell |
32,900
-28,400
| -46% | -$276K | ﹤0.01% | 7474 |
|
|
2019
Q4 | $536K | Buy |
61,300
+24,000
| +64% | +$199K | ﹤0.01% | 6709 |
|
|
2019
Q3 | $402K | Buy |
37,300
+20,300
| +119% | +$219K | ﹤0.01% | 7123 |
|
|
2019
Q2 | $216K | Sell |
17,000
-11,300
| -40% | -$260K | ﹤0.01% | 8083 |
|
|
2019
Q1 | $1.1M | Sell |
28,300
-62,000
| -69% | -$1.89M | ﹤0.01% | 5418 |
|
|
2018
Q4 | $1.84M | Buy |
90,300
+46,900
| +108% | +$1.41M | ﹤0.01% | 4274 |
|
|
2018
Q3 | $1.99M | Sell |
43,400
-16,400
| -27% | -$791K | ﹤0.01% | 4409 |
|
|
2018
Q2 | $3.54M | Buy |
59,800
+28,700
| +92% | +$1.66M | ﹤0.01% | 3255 |
|
|
2018
Q1 | $2.12M | Buy |
31,100
+1,800
| +6% | +$135K | ﹤0.01% | 3650 |
|
|
2017
Q4 | $2.9M | Buy |
29,300
+1,500
| +5% | +$168K | ﹤0.01% | 3140 |
|
|
2017
Q3 | $3.33M | Sell |
27,800
-15,000
| -35% | -$1.4M | ﹤0.01% | 2769 |
|
|
2017
Q2 | $3.74M | Buy |
42,800
+15,500
| +57% | +$867K | ﹤0.01% | 2433 |
|
|
2017
Q1 | $1.02M | Buy |
27,300
+9,100
| +50% | +$332K | ﹤0.01% | 3967 |
|
|
2016
Q4 | $559K | Buy |
18,200
+100
| +0.6% | +$4.32K | ﹤0.01% | 4727 |
|
|
2016
Q3 | $1.21M | Buy |
18,100
+3,200
| +21% | +$162K | ﹤0.01% | 3573 |
|
|
2016
Q2 | $444K | Sell |
14,900
-800
| -5% | -$25K | ﹤0.01% | 4656 |
|
|
2016
Q1 | $461K | Buy |
15,700
+9,200
| +142% | +$416K | ﹤0.01% | 4523 |
|
|
2015
Q4 | $510K | Sell |
6,500
-4,400
| -40% | -$345K | ﹤0.01% | 4446 |
|
|
2015
Q3 | $821K | Sell |
10,900
-1,200
| -10% | -$113K | ﹤0.01% | 4082 |
|
|
2015
Q2 | $1.41M | Sell |
12,100
-4,100
| -25% | -$742K | ﹤0.01% | 3505 |
|
|
2015
Q1 | $3.83M | Buy |
16,200
+2,900
| +22% | +$620K | ﹤0.01% | 2314 |
|
|
2014
Q4 | $2.52M | Sell |
13,300
-8,100
| -38% | -$1.8M | ﹤0.01% | 2652 |
|
|
2014
Q3 | $5.11M | Buy |
21,400
+14,800
| +224% | +$3.04M | 0.01% | 1968 |
|
|
2014
Q2 | $436K | Sell |
6,600
-2,900
| -31% | -$206K | ﹤0.01% | 4573 |
|
|
2014
Q1 | $989K | Buy |
+9,500
| New | +$1.12M | ﹤0.01% | 3440 |
|
Other funds holding PBYI
ACA
VCM
VPM
